W. Pérez

发表

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.

M. Pasquini, Stephanie J. Lee, B. Shaw, 2022, Transplantation and cellular therapy.

Veno‐occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation

W. Saber, C. Duncan, F. Loberiza, 2021, Pediatric blood & cancer.

Prior Gemtuzumab Ozogamicin Exposure in Adults With Acute Myeloid Leukemia Does Not Increase Hepatic Veno-occlusive Disease Risk After Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis.

W. Saber, V. Ho, F. Loberiza, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Patients with Primary Systemic Amyloidosis (AL): An Abmtr Study

M. Horowitz, D. Reece, C. Bredeson, 2004 .

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

H. Schrezenmeier, G. Socié, E. Gluckman, 2006, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

M. Norkin, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

syndrome and acute myeloid leukemia Allogeneic transplantation for therapy-related myelodysplastic

J. Sierra, J. Dipersio, S. Tarima, 2011 .

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

J. Sierra, J. Dipersio, S. Tarima, 2010, Blood.

Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.

J. Mehta, M. Tallman, G. Dewald, 2007, Blood.

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

M. Cazzola, H. Deeg, P. Greenberg, 2011 .

J. Szer, B. George, R. Gale, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.

C. Bloomfield, R. Larson, K. Mrózek, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.

H. Atkins, P. Hari, A. Dispenzieri, 2010, Clinical lymphoma, myeloma & leukemia.

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

P. Hari, R. Kyle, Shaji K. Kumar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of twin and autologous transplants for multiple myeloma.

R. Fonseca, P. Hari, R. Kyle, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

R. Gale, M. Bishop, O. Ringdén, 2011, Bone Marrow Transplantation.

Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research

J. Klein, M. Horowitz, R. Gale, 2006, British journal of haematology.

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

J. Klein, M. Horowitz, J. Passweg, 2007, Blood.

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.

Mei-Jie Zhang, David D. Smith, David D Smith, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity.

H. Deeg, M. Horowitz, Michael T. Hemmer, 2018, Blood advances.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

John P Klein, Daniel J Weisdorf, Peter Greenberg, 2004, Blood.

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

John P Klein, Daniel J Weisdorf, Ciril Rozman, 2002, Blood.

Bone marrow transplantation for diamond-blackfan anemia.

M. Pasquini, V. Roy, C. Bredeson, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

R. Schlenk, H. Döhner, A. Ganser, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.

M. Horowitz, M. Tallman, R. Gale, 2000, Blood.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

J. Klein, M. Horowitz, R. Gale, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

controlled study of conditioning regimens Bone marrow transplantation for severe aplastic anemia: a randomized

J. Klein, M. Horowitz, J. Passweg, 2013 .

Comparison o f P reparative R egimens i n T ransplants f or Children W ith A cute L ymphoblastic L eukemia

J. Klein, M. Horowitz, R. Gale, 2000 .

Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age

S. Jagannath, R. Kyle, J. Wingard, 2003, Bone Marrow Transplantation.

Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.

M. Cazzola, H. Deeg, P. Greenberg, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.

D. Heitjan, P. Hari, R. Kyle, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

IS THE INTERNATIONAL STAGING SYSTEM SUPERIOR TO THE DURIE SALMON STAGING SYSTEM? A COMPARISON IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT

P. Hari, R. Kyle, D. Reece, 2009, Leukemia.

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

J. Klein, R. Gale, M. Trigg, 2002, British journal of haematology.

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.

J. Szer, B. George, M. Tallman, 2010, Blood.

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research

J. Szer, M. Tallman, K. Ballen, 2013, Haematologica.

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.

H. Goldschmidt, P. Hari, D. Reece, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Sierra, M. Tallman, R. Gale, 2008, Blood.

Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research.

M. Pasquini, B. Shaw, K. Flynn, 2023, Transplantation and cellular therapy.

lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute

J. Sierra, R. Gale, M. Bishop, 2011 .

High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study.

D. Reece, D. Vesole, C. Bredeson, 2006, Mayo Clinic proceedings.

Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.

J. Sierra, A. Zander, M. Horowitz, 2006, Biology of Blood and Marrow Transplantation.

Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysis.

J. Klein, R. Gale, L. Akard, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of Outcomes for Non-Myeloablative (NMA) and Myeloablative (MA) Conditioning for Adults with Acute Lymphoblastic Leukaemia (ALL) in First and Second Complete Remission (CR): a Center for International Blood and Marrow Transplant Research (CIBMTR) Analyisis.

J. Dipersio, M. Tallman, Tao Wang, 2009 .

Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182].

P. Hari, M. Pasquini, M. Horowitz, 2021, Transplantation and Cellular Therapy.